Isaar Pharma launches peptide product for Vitiligo
Hyderabad based Issar Pharmaceuticals Pvt Ltd has developed a peptide-based lotion — Melgain —- for the treatment of Vitiligo.

Biocon denies deaths during clinical trials of R-human insulin
REACTING strongly to the reports that appeared in a section of the press, Bangalore-based Biocon has denied that there were any deaths during its clinical trials of re-combinant human insulin, which were carried out in ten institutions across the country.

Ind Swift to tie up with US firms for contract research
Chandigarh-based Ind Swift Laboratories Limited (ISLL), a part of the Rs 450-crore Ind Swift group, plans to forge alliances with US-based pharma companies for contract research. The company is seeking alliances in the US through its subsidiary set up there in March this year.

Dabur to acquire OTC brand
DABUR India is all set to acquire an over-the-counter (OTC) healthcare brand: a cough-n-cold product in the herbal domain, soon.

Ranbaxy receives tentative USFDA approval for Gabapentin capsules
Delhi - based Ranbaxy Laboratories Limited has received tentative approval from the US Food and Drug Administration to manufacture and market Gabapentin Capsules, 100 mg, 300 mg, and 400 mg, informed a press release.

Torrent Pharma earmarks Rs 100 crore for R&D
TORRENT Pharmaceuticals, the Ahmedabad-based pharma major, has earmarked Rs 100 crores to double its R&D infrastructure and operations over the next 18 months.

Wander, Pearl Organics merge to form Wanbury
Pearl Organics announced that it has received approval from the Mumbai High Court to proceed with its proposed scheme of amalgamation of Wander Pvt Limited with Pearl Organics Limited.

Chemgen Pharma: Conquering dreams
Dr Kali Pradip Chaudhuri, a US based Non-Resident Indian (NRI) and a renowned orthopedic surgeon had a dream of setting up a research organisation which realised with the setting up of Chemgen Pharma International in November 2003.